Colorectal and anal cancer in HIV/AIDS patients: a comprehensive review

References

• Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338(13):853-60
   PubMed Web of Science ®Google Scholar
• Panos G, Samonis G, Alexiou VG, et al. Mortality and morbidity of HIV infected patients receiving HAART: a cohort study. Curr HIV Res 2008;6(3):257-60
   Google Scholar
• Keiser O, Taffé P, Zwahlen M, et al. All cause mortality in the Swiss HIV Cohort Study from 1990 to 2001 in comparison with the Swiss population. AIDS 2004;18(13):1835-43
   Google Scholar
• Lanoy E, Spano JP, Bonnet F, et al. Distribution, characteristics, and prognostic of AIDS and non-AIDS cancers in HIV-infected patients, the ONCOVIH study. Infect Agent Cancer 2009;4(Suppl 2):O15
   Google Scholar
• Chiao EY. Epidemiology and clinical characteristics of non-AIDS-defining malignancies. In: Dittmer DP, Krown SE, editors. Molecular basis for therapy of AIDS-defining cancers springer science+business media. LLC, New York, USA; 2010. p. 17-40
   Google Scholar
• Engels EA, Goedert JJ. Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future. J Natl Cancer Inst 2005;97(6):407-9
   PubMed Web of Science ®Google Scholar
• Engels EA, Pfeiffer RM, Goedert JJ, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006;20(12):1645-54
   PubMed Web of Science ®Google Scholar
• Frisch M, Biggar RJ, Engels EA, et al. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001;285(13):1736-45
   PubMed Web of Science ®Google Scholar
• Grulich E. Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation. Curr Opin HIV AIDS 2009;4(3):183-7
   Google Scholar
• Franceschi S, Lise M, Clifford GM, et al. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer 2010;103(3):416-22
   PubMed Web of Science ®Google Scholar
• Bonnet F, Chene G. Evolving epidemiology of malignancies in HIV. Curr Opin Oncol 2008;20(5):534-40
   PubMed Web of Science ®Google Scholar
• Powles T, Robinson D, Stebbing J, et al. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol 2009;27(6):884-90
   PubMed Web of Science ®Google Scholar
• Cooksley CD, Hwang LY, Waller DK, et al. HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data. Int J STD AIDS 1999;10(12):795-802
   Google Scholar
• Lim ST, Levine AM. Non-AIDS-defining cancers and HIV infection. Curr HIV/AIDS Rep 2005;2(3):146-53
   Google Scholar
• Engels EA. Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities. AIDS 2009;23(8):875-85
   PubMed Web of Science ®Google Scholar
• Nguyen ML, Farrell KJ, Gunthel CJ. Non-AIDS-defining malignancies in patients with HIV in the HAART era. Curr Infect Dis Rep 2010;12(1):46-55
   Google Scholar
• Grulich AE, Wan X, Law MG, et al. Risk of cancer in people with AIDS. AIDS 1999;13(7):839-43
   PubMed Web of Science ®Google Scholar
• Crum-Cianflone NF, Hullsiek KH, Marconi VC, et al. Anal cancers among HIV-infected persons: HAART is not slowing rising incidence. AIDS 2010;24(4):535-43
   PubMed Web of Science ®Google Scholar
• Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005;97(6):425-32
   PubMed Web of Science ®Google Scholar
• van Leeuwen MT, Vajdic CM, Middleton MG, et al. Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy. AIDS 2009;23(16):2183-90
   PubMed Web of Science ®Google Scholar
• Piketty C, Selinger-Leneman H, Bouvier AM, et al. Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the French hospital database on HIV. J Clin Oncol 2012;30(35):4360-6
   PubMed Web of Science ®Google Scholar
• Piketty C, Selinger-Leneman H, Grabar S, et al. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS 2008;22(10):1203-11
   PubMed Web of Science ®Google Scholar
• Grulich AE, Li Y, McDonald A, et al. Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 2002;16(8):1155-61
   PubMed Web of Science ®Google Scholar
• Severini A. Anal intraepithelial neoplasia in men living with HIV in the era of highly active antiretroviral therapy. Clin Infect Dis 2011;52(9):1182-3
   Google Scholar
• de Pokomandy A, Rouleau D, Ghattas G, et al. HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV. Clin Infect Dis 2011;52(9):1174-81
   PubMed Web of Science ®Google Scholar
• Bower M, Powles T, Newsom-Davis T, et al. HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome? J Acquir Immune Defic Syndr 2004;37(5):1563-5
   PubMed Web of Science ®Google Scholar
• Herida M, Mary-Krause M, Kaphan R, et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 2003;21(18):3447-53
   Google Scholar
• De Vuyst H, Clifford GM, Nascimento MC, et al. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009;124(7):1626-36
   PubMed Web of Science ®Google Scholar
• Siegel R, Naishadham D, Jemal A. Cancer statistics 2012. CA Cancer J Clin 2012;62(1):10-29
   PubMed Web of Science ®Google Scholar
• Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review 1975-2010. National Cancer Institute. Bethesda, MD, USA; 2013
   Google Scholar
• Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 2009;104(3):739-50
   PubMed Web of Science ®Google Scholar
• Botteri E, Iodice S, Bagnardi V, et al. Smoking and colorectal cancer: a meta-analysis. JAMA 2008;300(23):2765-78
   PubMed Web of Science ®Google Scholar
• Potterat JJ, Brewer DD, Brody S. Receptive anal intercourse as a potential risk factor for rectal cancer. Cancer 2011;117(14):3284; author reply 3284-5
   Google Scholar
• Frisch M, Glimelius B, Wohlfahrt J, et al. Tobacco smoking as a risk factor in anal carcinoma: an antiestrogenic mechanism? J Natl Cancer Inst 1999;91(8):708-15
   PubMedGoogle Scholar
• Iqbal S, Browne-McDonald V, Cerulli MA. Recent trends for colorectal cancer screening in HIV-infected patients. Dig Dis Sci 2010;55(3):761-6
   PubMed Web of Science ®Google Scholar
• Bini EJ, Green B, Poles MA. Screening colonoscopy for the detection of neoplastic lesions in asymptomatic HIV-infected subjects. Gut 2009;58(8):1129-34
   Google Scholar
• Bini EJ, Park J, Francois F. Use of flexible sigmoidoscopy to screen for colorectal cancer in HIV-infected patients 50 years of age and older. Arch Intern Med 2006;166(15):1626-31
   Google Scholar
• Reinhold JP, Moon M, Tenner CT, et al. Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention. Am J Gastroenterol 2005;100(8):1805-12
   PubMed Web of Science ®Google Scholar
• Palefsky JM, Holly EA, Efirdc JT, et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 2005;19(13):1407-14
   PubMed Web of Science ®Google Scholar
• Rosa-Cunha I, Degennaro VA, Hartmann R, et al. Description of a pilot anal pap smear screening program among individuals attending a Veteran's Affairs HIV clinic. AIDS Patient Care STDS 2011;25(4):213-19
   Google Scholar
• Palefsky J. Human papillomavirus and anal neoplasia. Curr HIV/AIDS Rep 2008;5(2):78-85
   Google Scholar
• Scott H, Khoury J, Moore BA, et al. Routine anal cytology screening for anal squamous intraepithelial lesions in an urban HIV clinic. Sex Transm Dis 2008;35(2):197-202
   Google Scholar
• Chiao EY, Giordano TP, Palefsky JM, et al. Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review. Clin Infect Dis 2006;43(2):223-33
   PubMed Web of Science ®Google Scholar
• Lam JM, Hoch JS, Tinmouth J, et al. Cost-effectiveness of screening for anal precancers in HIV-positive men. AIDS 2011;25(5):635-42
   PubMed Web of Science ®Google Scholar
• Czoski-Murray C, Karnon J, Jones R, et al. Cost-effectiveness of screening high-risk HIV-positive men who have sex with men (MSM) and HIV-positive women for anal cancer. Health Technol Assess 2010;14(53):iii-v; ix-x, 1-101
   Google Scholar
• Karnon J, Jones R, Czoski-Murray C, et al. Cost-utility analysis of screening high-risk groups for anal cancer. J Public Health (Bangkok) 2008;30(3):293-304
   Google Scholar
• Goldie SJ, Kuntz KM, Weinstein MC, et al. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. Jama 1999;281:1822-9
   PubMed Web of Science ®Google Scholar
• Freedberg KA, Scharfstein JA, Seage GR III, et al. The cost-effectiveness of preventing AIDS-related opportunistic infections. JAMA 1998;279(2):130-6
   PubMed Web of Science ®Google Scholar
• Inadomi JM. Update on the cost-effectiveness of screening for colorectal neoplasia. Curr Opin Gastroenterol 2003;19(1):44-50
   Google Scholar
• Lazenby GB, Unal ER, Andrews AL, et al. A cost-effectiveness analysis of anal cancer screening in HIV-positive women. J Low Genit Tract Dis 2012;16(3):275-80
   Google Scholar
• Palefsky JM, Giuliano AR, Goldstone S, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011;365(17):1576-85
   PubMed Web of Science ®Google Scholar
• Hoots BE, Palefsky JM, Pimenta JM, et al. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009;124(10):2375-83
   PubMed Web of Science ®Google Scholar
• Wilkin T, Lee JY, Lensing SY, et al. Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men. J Infect Dis 2010;202(8):1246-53
   PubMed Web of Science ®Google Scholar
• Gallagher B, Wang Z, Schymura MJ, et al. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol 2001;154(6):544-56
   Google Scholar
• Biggar RJ, Kirby KA, Atkinson J, et al. Cancer risk in elderly persons with HIV/AIDS. J Acquir Immune Defic Syndr 2004;36(3):861-8
   PubMed Web of Science ®Google Scholar
• Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000;92(22):1823-30
   Google Scholar
• Long JL, Engels EA, Moore RD, et al. Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS 2008;22(4):489-96
   PubMedGoogle Scholar
• Grulich AE, van Leeuwen MT, Falster MO, et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007;370(9581):59-67
   PubMed Web of Science ®Google Scholar
• Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008;148(10):728-36
   PubMed Web of Science ®Google Scholar
• Newnham A, Harris J, Evans HS, et al. The risk of cancer in HIV-infected people in southeast England: a cohort study. Br J Cancer 2005;92(1):194-200
   Google Scholar
• Petruckevitch A, Del Amo J, Phillips AN, et al. Risk of cancer in patients with HIV disease. London African HIV/AIDS Study Group. Int J STD AIDS 1999;10(1):38-42
   Google Scholar
• Goedert JJ, Coté TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet 1998;351(9119):1833-9
   PubMedGoogle Scholar
• Bedimo R, Chen RY, Accortt NA, et al. Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002. Clin Infect Dis 2004;39(9):1380-4
   Google Scholar
• Shiels MS, Pfeiffer RM, Gail MH, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst 2011;103(9):753-62
   PubMedGoogle Scholar
• Li Y, Law M, McDonald A, et al. Estimation of risk of cancers before occurrence of acquired immunodeficiency syndrome in persons infected with human immunodeficiency virus. Am J Epidemiol 2002;155(2):153-8
   Google Scholar
• Shiels MS, Pfeiffer RM, Engels EA. Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med 2010;153(7):452-60
   PubMed Web of Science ®Google Scholar
• Chapman C, Aboulafia DM, Dezube BJ, et al. Human immunodeficiency virus-associated adenocarcinoma of the colon: clinicopathologic findings and outcome. Clin Colorectal Cancer 2009;8(4):215-19
   Google Scholar
• Berretta M, Cappellani A, Di Benedetto F, et al. Clinical presentation and outcome of colorectal cancer in HIV-positive patients: a clinical case-control study. Onkologie 2009;32(6):319-24
   Google Scholar
• Kumar A, Shah N, Modi Y, et al. Characteristics of colorectal cancer in the human immunodeficiency virus-infected African American population. Med Oncol 2012;29(3):1773-9
   Google Scholar
• Alfa-Wali M, Tait D, Allen-Mersh T, et al. Colorectal cancer in HIV positive individuals: the immunological effects of treatment. Eur J Cancer 2011;47(16):2403-7
   Google Scholar
• Wasserberg N, Nunoo-Mensah JW, Gonzalez-Ruiz C, et al. Colorectal cancer in HIV-infected patients: a case control study. Int J Colorectal Dis 2007;22(10):1217-21
   Google Scholar
• Berretta M, Di Benedetto F, Simonelli C, et al. Multidisciplinary approach in a HIV/HCV-positive patient with liver metastases by colorectal cancer in the HAART era. Ann Oncol 2006;17(8):1333-4
   PubMed Web of Science ®Google Scholar
• Berretta M, Lleshi A, Cappellani A, et al. Oxaliplatin based chemotherapy and concomitant highly active antiretroviral therapy in the treatment of 24 patients with colorectal cancer and HIV infection. Curr HIV Res 2010;8(3):218-22
   Google Scholar
• Berretta M, Zanet E, Basile F, et al. HIV-positive patients with liver metastases from colorectal cancer deserve the same therapeutic approach as the general population. Onkologie 2010;33(4):203-4
   Google Scholar
• Diamond C, Taylor TH, Aboumrad T, et al. Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy. Sex Transm Dis 2005;32(5):314-20
   PubMed Web of Science ®Google Scholar
• Chiao EY, Giordano TP, Richardson P, et al. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era. J Clin Oncol 2008;26(3):474-9
   Web of Science ®Google Scholar
• Wexler A, Berson AM, Goldstone SE, et al. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy. Dis Colon Rectum 2008;51(1):73-81
   Google Scholar
• Silverberg MJ, Lau B, Justice AC, et al. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infec Dis 2012;54(7):1026-34
   PubMed Web of Science ®Google Scholar
• Fraunholz I, Rabeneck D, Gerstein J, et al. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for anal carcinoma: are there differences between HIV-positive and HIV-negative patients in the era of highly active antiretroviral therapy? Radiother Oncol 2011;98(1):99-104
   Google Scholar
• Piketty C, Darragh TM, Da Costa M, et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med 2003;138(6):453-9
   PubMed Web of Science ®Google Scholar
• Stadler RF, Gregorcyk SG, Euhus DM, et al. Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy. Dis Colon Rectum 2004;47(8):1305-9
   Google Scholar
• Edelman S, Johnstone PA. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities. Int J Radiat Oncol Biol Phys 2006;66(1):206-11
   Google Scholar
• Palefsky J. Biology of HPV in HIV infection. Adv Dent Res 2006;19(1):99-105
   PubMedGoogle Scholar
• Piketty C, Kazatchkine MD. Human papillomavirus-related cervical and anal disease in HIV-infected individuals in the era of highly active antiretroviral therapy. Curr HIV/AIDS Rep 2005;2(3):140-5
   Google Scholar
• Aberg JA, Kaplan JE, Libman H, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2009;49(5):651-81
   PubMed Web of Science ®Google Scholar